{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-023367","form_type":"8-K","ticker":"PULM","cik":"0001574235","company_name":"Pulmatrix, Inc.","filed_at":"2026-05-15T12:20:20+00:00","discovered_at":"2026-05-15T12:25:00.213299+00:00","generated_at":"2026-05-15T12:26:51.220799+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Pulmatrix Q1 net loss $1.2M, cash $3.3M; merger with Eos SENOLYTIX set for Q3 2026","bullets":["Net loss $1.172M ($0.32/share) vs $1.808M ($0.50/share) in Q1 2025; no revenue reported.","Cash and equivalents $3.3M at March 31, 2026; going concern assumed through anticipated merger close.","Merger agreement with Eos SENOLYTIX signed March 26, 2026; expected close Q3 2026; common stock holders get ~6% of combined co.","Private placement of Series B convertible preferred stock from Eos affiliate raised $1.0M gross in March.","R&D expense <$0.1M; G&A down to $1.3M from $1.8M; clinical programs on hold pending out-license."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-023367","json":"https://secwatch.observer/filing/0001493152-26-023367.json","markdown":"https://secwatch.observer/filing/0001493152-26-023367.md","text":"https://secwatch.observer/filing/0001493152-26-023367.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1574235/000149315226023367/0001493152-26-023367-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1574235/000149315226023367/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T12:26:51.220799+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c739f0bf8a727f8fd741104ceea4af031c0c9f6e","claim":"Pulmatrix, Inc. reported financial results for first fiscal quarter ended March 31, 2026.","evidence_excerpt":"Pulmatrix, Inc. issued a press release announcing its financial results for the first fiscal quarter ended March 31, 2026","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1574235/000149315226023367/0001493152-26-023367-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first fiscal quarter ended March 31, 2026"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}